# FDA Inspection 1171011 - Central Pennsylvania Blood Bank - May 06, 2022

Source: https://www.keypedia.com/records/fda_inspections/central-pennsylvania-blood-bank/d056f76e-d24f-4564-a323-37e7a6bf3fee
Source feed: FDA_Inspections

> FDA Inspection 1171011 for Central Pennsylvania Blood Bank on May 06, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1171011
- Company Name: Central Pennsylvania Blood Bank
- Inspection Date: 2022-05-06
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1171011 - 2022-05-06](https://www.keypedia.com/records/fda_inspections/central-pennsylvania-blood-bank/2ded738e-e102-415a-aebb-54172d61432b)

Company: https://www.keypedia.com/companies/central-pennsylvania-blood-bank/979beab4-0c58-4a03-b817-816c3dca104a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d